Financials

News Ideas Discussions Technicals Forecast

ADAP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Adaptimmune Therapeutics plc

Total assets of ADAP for Q2 24 is 321.70 M USD, 24.69% more than the previous Q1 24. And total liabilities decreased by 3.51% in Q2 24 to 225.43 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—